Canine epilepsy requires long-term medical management balancing seizure control against medication side effects, with quality of life monitoring essential throughout a dog's treatment journey.
Canine epilepsy management requires ongoing attention to quality of life across multiple dimensions. Seizures themselves are acutely distressing events — generalised tonic-clonic seizures involve loss of consciousness, violent muscle activity, and a post-ictal period of confusion, anxiety, and disorientation lasting minutes to hours. High seizure frequency significantly impairs welfare by repeatedly disrupting normal behaviour and causing cumulative neurological stress. However, medication side effects must also be weighed: phenobarbital causes sedation, increased appetite, and increased thirst in some dogs, while hepatotoxicity from long-term use requires regular monitoring. Effective seizure control with acceptable side effects represents the target; this balance is individual and requires iterative adjustment. Quality of life assessment tools specifically validated for epileptic dogs, such as the ICES (Impact of Canine Epilepsy on Seizure) scale, help owners and veterinarians monitor welfare systematically. Dogs experiencing more than one seizure per month, prolonged post-ictal periods, or significant medication side effects warrant protocol review.